About
Digital Neuromodulation Therapy
Areas of Focus
Categories
Uncategorized Medical DeviceMiddle East
Team (7)
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
683
By Phase
NA: 7PHASE3: 1
By Status
COMPLETED: 6WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05804396Lead Sponsor
Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine
NAWithdrawn
Started: Nov 24, 2024 · Completed: Nov 24, 2024
NCT05178784Collaborator
"EEG Biomarker Study for Participants in the Neurolief MOOD Trial"
N/AActive, not recruiting
40 participants
Started: Nov 16, 2021 · Completed: Nov 16, 2025
NCT04279522Lead Sponsor
The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)
NACompleted
124 participants
Started: Aug 31, 2021 · Completed: Jun 7, 2024
NCT03631550Lead Sponsor
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
NACompleted
187 participants
Started: Nov 29, 2018 · Completed: Aug 4, 2020
NCT03398668Lead Sponsor
Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
NACompleted
55 participants
Started: Feb 22, 2018 · Completed: Dec 30, 2018
Locations (1)
Headquarters
Netanya, Israel
Map
Loading map...